EBS Emergent Biosolutions Inc

Emergent BioSolutions Inc is a biotechnology company operating in two divisions: biodefense and biosciences. The company focuses on countermeasures that address public health threats around hematology and oncology therapeutics.

$61.85  +1.80 (3.00%)
As of 06/24/2021 16:00:02 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  11/15/2006
Outstanding shares:  53,585,478
Average volume:  742,074
Market cap:   $3,153,505,380
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    29089Q105
ISIN:        US29089Q1058
Sedol:      B1HJLW5
Valuation   (See tab for details)
PE ratio:   8.31
PB ratio:   2.11
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy